Oculer
Oculer Limited is an Irish company that developed the Oculer Rapid 930 Series, an automated benchtop microbiological testing platform using luminescent oxygen-sensor technology for food, beverage, and pharmaceutical QC labs. It is now in Members Voluntary Liquidation.
- Company typePrivate
- Founded2011
- HeadquartersBallina, Ireland
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What Oculer does
Oculer Limited was an Irish private company that developed and commercialized the Oculer Rapid 930 Series, a fully automated benchtop incubator and reader for rapid microbiological quality testing in food, beverage, and pharmaceutical/cleanroom environments. The system uses a luminescent oxygen sensor to continuously measure oxygen depletion inside proprietary, gamma-irradiated, bar-coded APCheck vials prefilled with bioengineered selective culture media. As target microorganisms respire and consume oxygen, the fluorescent sensor reacts, enabling detection of growth without traditional plate counting. The platform supports an assay menu covering Total Viable Count, Yeast & Mould Detection, Commercial Sterility (CS-Check), Alicyclobacillus, Environmental Monitoring (EM-Check), and Gram Positive/Negative Screening, with reported sensitivity down to 1 cfu per 10 mL sample volume and results available 24-72 hours faster than conventional plate methods. Manufacturing of the instrument was outsourced to RTR Electronics Ltd in County Limerick, Ireland.
Oculer's business model combined upfront instrument sales (the 930-15 and 930-2 models, each handling 24 or 48 simultaneous tests respectively) with recurring consumable revenue from APCheck assay vials, supplemented by technical support services spanning needs analysis, in-house product testing, installation, on-site training, and ongoing QC program design. Pricing was quote-based with multi-year commercial packages structured to avoid large upfront capital expenditure for customers. Distribution was hybrid: direct sales in core regions complemented by selected distribution partners with industrial microbiology expertise in other geographies. The company served primarily food and beverage manufacturers, dairy processors, fruit juice and beverage producers, and pharmaceutical cleanroom operations in Ireland and the United Kingdom.
Oculer carried Microval and AOAC validations (formerly under the GreenLight trademark) and was pursuing BS EN ISO 9001:2015 QMS accreditation. As of the most recent source data, Oculer Limited is in Members Voluntary Liquidation, a solvent shareholder-initiated wind-down, and the operating business has effectively ceased. The founding directors and shareholders were Malcolm Bell (Chairman), Peter Thornton (CFO), Brian Byrne (CEO), and Prof. Colin Fricker (CSO and Head of Product Development).
Oculer firmographics
Firmographics- Name
- Oculer
- Legal name
- Oculer Limited
- Website
- https://oculer.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Closed
- Headcount range
- 1–10 employees
- Short description
- Oculer Limited is an Irish company that developed the Oculer Rapid 930 Series, an automated benchtop microbiological testing platform using luminescent oxygen-sensor technology for food, beverage, and pharmaceutical QC labs. It is now in Members Voluntary Liquidation.
- Ownership category
- akta.pro rank
Oculer industry classification
Industry- Product category
- Industrial Microbiology Testing Equipment
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens) (AFALAEAD)
- akta.pro secondary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
Keywords
Where Oculer is headquartered
LocationHeadquarters
- HQ city
- Ballina
- HQ country
- Ireland
- HQ region
- Europe
Offices1 record
Markets served
Oculer business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D
Revenue model
- Instrument Sales: Sale of Oculer Rapid 930 Series instruments (930-15 and 930-2 models) as benchtop incubator/readers. Instruments are designed to be low-cost compared to other rapid test technologies and can avoid large capital expenditure upfront for customers.
- Assay Kit Sales: Sale of ready-to-use gamma-irradiated assay vials prefilled with bioengineered growth media. Vials are bar-coded for full traceability and available for various assay types including TVC, Yeast & Mould, Commercial Sterility, Alicyclobacillus, Environmental Monitoring, and Gram Positive/Negative.
- Technical Support Services: Comprehensive technical support including customer needs analysis, product testing in Oculer's laboratory, installation, on-site training, in-situ technology evaluation, and ongoing technical support for customers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for instruments and assays |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Oculer product offering
Product offeringCore offering
Oculer develops and sells the Oculer Rapid 930 Series, a fully automated benchtop incubator and reader that detects microbial growth by continuously measuring oxygen depletion within culture vials using a proprietary luminescent sensor. The platform is paired with a range of ready-to-use, gamma-irradiated assay kits (Total Viable Count, Yeast & Mould, Commercial Sterility, Alicyclobacillus, Environmental Monitoring, and Gram Positive/Negative Screening) and accompanying software for data traceability and LIMS integration, sold primarily to food and beverage manufacturers.
Product overview
Oculer offers a unified product ecosystem centered on the Oculer Rapid 930 Series benchtop incubator/reader combined with a range of proprietary assay kits and consumables. The core system uses luminescent oxygen sensor technology to detect microbial growth, with assays including Total Viable Count, Yeast & Mould Detection, Commercial Sterility (CS-Check), Gram Positive/Negative Screening, Alicyclobacillus, and Environmental Monitoring (EM-Check). All assays use pre-filled, gamma-irradiated APCheck vials with bar-coded traceability. The software platform provides integrated analytics with LIS/LIMS connectivity. The company was formerly marketed as GreenLight and continues to offer validated assays for food and beverage quality testing.
Differentiator
Problem solved
Functional benefit
Products and services
- Oculer Rapid 930 Series Automated Incubator and Reader
Quantifiable outcome
- Up to 100x more sensitive than traditional plate methods
- +4 more outcomes
Companies that use Oculer
Customer profileSegments4 records
Ideal customer profiles1 record
Oculer technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Oculer partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- RTR Electronics LtdcoreRTR Electronics Ltd is Oculer's manufacturing partner for the manufacture of the Rapid 930 Series instruments at its facility at Annacotty, Co Limerick, Ireland. RTR has been assessed and registered by NQA against the provisions of BS EN ISO 9001:2015.
- Geographic Distribution PartnersminorOculer is represented by well-established distribution partners in certain geographical markets. Partners are carefully chosen for their deep knowledge of the technology, quality of their dedicated and trained technical support personnel, and their long track record in working with industrial microbiology laboratories around the globe.
Scale indicators5 records
Recent moves7 records
Expansion highlights4 records
Oculer competitors and assessment
Company assessmentBroad incumbents
- MilliporeSigma (Merck KGaA Life Science): Supplies microbiology testing consumables, prepared media, and detection platforms used in industrial QC labs. Overlaps with Oculer's assay-kit and prepared-media offering within the same food and beverage QC workflow.
- SGS: Global testing, inspection, and certification company with extensive food and beverage microbiology service capabilities. Competes for the same QC budget by offering outsourced testing as an alternative to in-house rapid platforms.
- Charles River Laboratories: Provides testing services and endotoxin/microbial detection products. Overlaps with Oculer in industrial and pharmaceutical QC microbiology, especially for cleanroom and sterility testing adjacent to Oculer's EM-Check offering.
- Mérieux NutriSciences: Food safety and quality testing services arm affiliated with Institut Mérieux. Provides outsourced microbiological testing for food and beverage manufacturers that could otherwise purchase in-house systems such as the Rapid 930.
- Eurofins Scientific: Largest food testing services network globally. While primarily a contract laboratory rather than instrument vendor, it competes for the same QC budget by offering outsourced testing as an alternative to in-house rapid platforms like Oculer's.
Direct peers
- Hygiena: Specialises in rapid ATP hygiene monitoring and PCR-based microbial detection for food and beverage manufacturers. Comparable target customers, sales-led GTM, and product positioning around shorter time-to-result versus traditional plating.
- Neogen Corporation: Food safety testing company that acquired 3M's Food Safety business, offering rapid indicator organism, pathogen, and hygiene monitoring assays across food processors. Comparable customer base (food and beverage QC labs) and overlapping product positioning with Oculer's rapid method portfolio.
- Bio-Rad Laboratories: Provides iQ-Check real-time PCR kits and other rapid microbiology solutions used in food and beverage QC. Directly competes in the rapid microbial detection category and serves overlapping industrial microbiology laboratories.
- R-Biopharm: German developer of lateral-flow, PCR, and immunoassay kits for food and feed pathogen/contaminant testing. Targets the same food and beverage QC customer profile and competes in rapid microbiological and hygiene monitoring workflows.
- bioMérieux: Global leader in industrial microbiology with rapid methods (e.g., TEMPO, BioBall) for food and beverage QC. Directly competes with Oculer in TVC and yeast/mould detection for dairy and beverage manufacturers, with a much broader assay menu and global service network.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Oculer social profiles
Digital presenceOculer compliance and trust
Trust signalCompliance2 records
Oculer financial estimates
Financial estimateRevenue estimate
Valuation estimate
Oculer leadership team
Management profileNumber of profiles
Profiles4 records
Oculer funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Oculer M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Oculer
What does Oculer do?
Oculer develops and sells the Oculer Rapid 930 Series, a fully automated benchtop incubator and reader that detects microbial growth by continuously measuring oxygen depletion within culture vials using a proprietary luminescent sensor. The platform is paired with a range of ready-to-use, gamma-irradiated assay kits (Total Viable Count, Yeast & Mould, Commercial Sterility, Alicyclobacillus, Environmental Monitoring, and Gram Positive/Negative Screening) and accompanying software for data traceability and LIMS integration, sold primarily to food and beverage manufacturers.
Is Oculer a public or private company?
Oculer is a private company. It is classified as founder individual operated bootstrapped and is currently closed.
When was Oculer founded?
Oculer was founded in 2011. It employs 1 to 10 people.
Where is Oculer based?
Oculer is headquartered in Ballina, Ireland, in the Europe region.
How does Oculer make money?
Three revenue lines are on record. Instrument Sales are the primary driver. The others are assay Kit Sales and technical Support Services.
Who are Oculer's main competitors?
Broad incumbents on record are MilliporeSigma (Merck KGaA Life Science), SGS, Charles River Laboratories, Mérieux NutriSciences and Eurofins Scientific. Direct peers are Hygiena, Neogen Corporation, Bio-Rad Laboratories, R-Biopharm and bioMérieux.
Does Oculer have an API?
No public API is recorded for Oculer.
What industry is Oculer in?
Oculer's product category is Industrial Microbiology Testing Equipment. Its primary akta.pro industry code is AFALAEAD, Air & Aerosol Monitoring (Bioaerosols, Mold, Yeast, Airborne Pathogens), with a secondary code of HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes). Its NAICS code is 334516 and its SIC code is 3826.